Search results for "being"

showing 10 items of 1477 documents

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (…

2015

ABSTRACT The DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) aims to provide recommendations for definitions of time-to-event end points in cancer randomized controlled trials. We relied on a consensus method based on a multidisciplinary panel of experts to develop these guidelines for trials on sarcomas and gastrointestinal stromal tumors. Background The use of potential surrogate end points for overall survival, such as disease-free survival (DFS) or time-to-treatment failure (TTF) is increasingly common in randomized controlled trials (RCTs) in cancer. However, the definition of time-to-event (TTE) end points is rarely precise and lacks unif…

medicine.medical_specialtyConsensusTime FactorssarcomaDelphi TechniqueEndpoint Determination[SDV]Life Sciences [q-bio]Disease-Free Survivallaw.invention03 medical and health sciencesgastrointestinal stromal tumors0302 clinical medicineRandomized controlled trialSDG 3 - Good Health and Well-beinglawMultidisciplinary approachTerminology as TopicmedicineHumansMedical physicsTreatment Failureguidelinestime-to-event end pointComputingMilieux_MISCELLANEOUSRandomized Controlled Trials as Topic030304 developmental biologyEvent (probability theory)0303 health sciencesEnd pointGiSTSurrogate endpointbusiness.industryefficacy measureCancerHematologymedicine.disease3. Good healthOncologyResearch Design030220 oncology & carcinogenesisrandomized controlled trialDisease ProgressionRadiologySarcomabusiness
researchProduct

Professional diagnostic delay in osteosarcomas of the jaws

2020

A series of 20 consecutive patients with an osteosarcoma of the jaws has been evaluated with regard to possible professional diagnostic delay. When set at an arbitrarily chosen period beyond three months, professional delay occurred in 15 patients, the mean being 21 months and the median 11 months. In five of the 15 patients a wrong diagnosis has been rendered on the biopsy specimen, being fibrous dysplasia (2x), osteoma (2x) and, in case of palatomaxillary swelling, pleomorphic adenoma (1x). In the other ten patients the initial clinicoradiographic features were misleading and apparently not indicative of a malignancy, except for one patient in whom a distinct widening of the periodontal l…

medicine.medical_specialtyDelayed DiagnosisBone NeoplasmsDelayed diagnosisMalignancyPleomorphic adenoma03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingBiopsymedicineHumansGeneral DentistryOsteomaOsteosarcomamedicine.diagnostic_testbusiness.industryResearchFibrous dysplasia030206 dentistryPrognosisMedically compromised patients in Dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseOtorhinolaryngologyUNESCO::CIENCIAS MÉDICAS/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingOsteosarcomaSurgeryRadiologybusiness
researchProduct

New loci associated with kidney function and chronic kidney disease

2010

Chronic kidney disease (CKD) is a significant public health problem, and recent genetic studies have identified common CKD susceptibility variants. The CKDGen consortium performed a meta-analysis of genome-wide association data in 67,093 individuals of European ancestry from 20 predominantly population-based studies in order to identify new susceptibility loci for reduced renal function as estimated by serum creatinine (eGFRcrea), serum cystatin c (eGFRcys) and CKD (eGFRcrea 60 ml/min/1.73 m 2; n = 5,807 individuals with CKD (cases)). Follow-up of the 23 new genome-wide-significant loci (P 5 × 10 8) in 22,982 replication samples identified 13 new loci affecting renal function and CKD (in or…

medicine.medical_specialtyGENOME-WIDE ASSOCIATION ; SERUM CREATININE ; PROTEIN ; GENE ; MUTATIONS ; VARIANTS ; POPULATION ; CANDIDATE ; HOMOLOG ; MEGALINPopulationRenal functionGenome-wide association studyBiologyKidneyurologic and male genital diseasesCohort Studieschemistry.chemical_compoundSDG 3 - Good Health and Well-beingRisk FactorsInternal medicineGenetic MarkermedicineGeneticsHumansCystatin CeducationCystatin C/geneticsddc:616Genetic Markers/geneticsCreatinineKidneyeducation.field_of_studyModels GeneticRisk Factorchronic kidney disease; loci; SNPCreatinine/bloodmedicine.diseaseDietEuropeKidney/*physiologyEndocrinologymedicine.anatomical_structurechemistryCystatin CRenal physiologyCreatininebiology.proteinKidney Failure ChronicKidney Failure Chronic/ethnology/*geneticsCohort StudieKidney diseaseHumanGenome-Wide Association StudyGlomerular Filtration Rate
researchProduct

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.

2020

Abstract Patients with Philadelphia-negative myeloproliferative neoplasm (MPN) are prone to the development of second cancers, but the factors associated with these events have been poorly explored. In an international nested case-control study, we recruited 647 patients with carcinoma, nonmelanoma skin cancer, hematological second cancer, and melanoma diagnosed concurrently or after MPN diagnosis. Up to 3 control patients without a history of cancer and matched with each case for center, sex, age at MPN diagnosis, date of diagnosis, and MPN disease duration were included (n = 1234). Cases were comparable to controls for MPN type, driver mutations and cardiovascular risk factors. The freque…

medicine.medical_specialtyImmunologyKaplan-Meier EstimateGene mutationBiochemistryGastroenterologyMyeloproliferative neoplasms03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingInternal medicineCarcinomaMedicineHumansPhiladelphia ChromosomeMyeloproliferative neoplasmMyeloproliferative Disordersbusiness.industryCase-control studyCancerfood and beveragesMyeloproliferative neoplasmssecond cancersarterial eventsNeoplasms Second PrimaryThrombosisCell BiologyHematologyOdds ratioArteriesmedicine.diseasesecond cancersThrombosisSettore MED/15 - MALATTIE DEL SANGUEarterial events030220 oncology & carcinogenesisCase-Control StudiesMultivariate Analysis/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSkin cancerbusiness030215 immunologyFollow-Up StudiesBlood
researchProduct

Improving Oral–Systemic Healthcare through the Interoperability of Electronic Medical and Dental Records: An Exploratory Study

2019

Objectives Electronic health records (EHRs) are rarely shared among medical and dental providers. The purpose of this study was to assess current information sharing and the value of improved electronic information sharing among physicians and dentists in Germany and the United States. Materials and Methods A survey was validated and distributed electronically to physicians and dentists at four academic medical centers. Respondents were asked anonymously about EHR use and the medical and dental information most valuable to their practice. Results There were 118 responses, a response rate of 23.2%. The majority (63.9%) of respondents were dentists and the remainder were physicians. Most res…

medicine.medical_specialtyInformation transferdentalClinical SciencesInteroperabilityDentistsExploratory researchHealth Informaticsintegratedmedical recordOral and gastrointestinalLikert scaleHealth Information ManagementClinical ResearchPhysiciansHealth carepatient safetymedicineElectronic Health RecordsHumansDental/Oral and Craniofacial Diseasehealthcare deliveryResponse rate (survey)business.industryInformation DisseminationInformation sharingDental RecordsHealth ServicesComputer Science ApplicationsTest (assessment)Good Health and Well Beingelectronic health recordsNetworking and Information Technology R&D (NITRD)Family medicinetechnologybusinessDelivery of Health CareInformation Systems
researchProduct

Oral leukoplakia: the ongoing discussion on definition and terminology

2015

In the past decades several definitions of oral leukoplakia have been proposed, the last one, being authorized by the World Health Organization (WHO), dating from 2005. In the present treatise an adjustment of that definition and the 1978 WHO definition is suggested, being : “A predominantly white patch or plaque that cannot be characterized clinically or pathologically as any other disorder; oral leukoplakia carries an increased risk of cancer development either in or close to the area of the leukoplakia or elsewhere in the oral cavity or the head-and-neck region”. Furthermore, the use of strict diagnostic criteria is recommended for predominantly white lesions for which a causative factor…

medicine.medical_specialtyKeratosisDentistryOdontologíaReviewOral cavityTerminologyLesionstomatognathic systemSDG 3 - Good Health and Well-beingTerminology as TopicmedicineHumansGeneral DentistryLeukoplakiaOral Medicine and Pathologybusiness.industryDecision Treesmedicine.disease:CIENCIAS MÉDICAS [UNESCO]DermatologyCiencias de la saludOral leukoplakiastomatognathic diseasesIncreased riskOtorhinolaryngologyUNESCO::CIENCIAS MÉDICAS/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSurgeryCancer developmentmedicine.symptomLeukoplakia Oralbusiness
researchProduct

Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients

2021

Introduction: Lung cancer is the deadliest and most prevalent cancer worldwide. Lung cancer treatments have different characteristics and are associated with a range of benefits and side effects for patients. Such differences may raise uncertainty among drug developers, regulators, payers, and clinicians regarding the value of these treatment effects to patients. The value of conducting patient preference studies (using qualitative and/or quantitative methods) for benefits and side effects of different treatment options has been recognized by healthcare stakeholders, such as drug developers, regulators, health technology assessment bodies, and clinicians. However, evidence-based guidelines …

medicine.medical_specialtyLung NeoplasmsDecision Making03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingCarcinoma Non-Small-Cell LungNominal group techniqueMethodsmedicineHumans030212 general & internal medicineLung cancerQualitative ResearchReimbursementpatient involvementbusiness.industrylcsh:Public aspects of medicinePublic Health Environmental and Occupational HealthHealth technologyCancerPatient Preferencelcsh:RA1-1270medicine.diseaseFocus groupdrug developmentlung cancerDrug developmentnominal group technique030220 oncology & carcinogenesisFamily medicinefocus group discussiondrug decision-makingPublic Healthbusinesspatient preferencesQualitative researchpatient-centered research
researchProduct

The Role of Pediatricians in Caring for the Well-Being of Children Living in New Types of Families.

2017

Pediatricians are on the front line of child care and advocacy, and it is their role to promote children's well-being and to help parents raise healthy children, independent of the configuration of their families. This report aims to draw attention to the evolving social scenarios and to emphasize that pediatricians must be trained to coordinate new challenges that may arise from differently configured families, particularly single-parent and same-sex–parent families.

medicine.medical_specialtyMEDLINEChild WelfareRM1-950Child health03 medical and health sciences0302 clinical medicinewell-being030225 pediatricsHumansMedicine0501 psychology and cognitive sciencesPediatriciansPhysician's Rolechild careFamily CharacteristicsChild carechildbusiness.industryFamily characteristics05 social scienceslcsh:RM1-950Child Healthpediatricianfamilieslcsh:Therapeutics. PharmacologySettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAFamily medicinePediatrics Perinatology and Child HealthWell-beingTherapeutics. PharmacologybusinessDelivery of Health Care050104 developmental & child psychology
researchProduct

How general dentists could manage a patient with oral lichen planus

2018

Background The literature hardly contains information on how patients suffering from oral lichen planus could be managed by dentists. Material and Methods Based on the limited available literature and particularly on the long-term clinical and histopathological experience of one of the authors, suggestions on how dentists could manage patients with oral lichen planus have been put forward. Results: In most cases, the dentist should be able to establish a correct diagnosis. Results In most cases, the dentist should be able to establish a correct diagnosis. Occasionally, the dentist may call upon a specialist, usually an oral medicine specialist or an oral and maxillofacial surgeon for confir…

medicine.medical_specialtyMEDLINEOral Medicine SpecialistReview03 medical and health sciences0302 clinical medicinestomatognathic systemSDG 3 - Good Health and Well-beingPatient informationmedicineHumansOral Diagnosisskin and connective tissue diseasesGeneral DentistryBiopsy procedureOral therapyOral Medicine and Pathologyintegumentary systembusiness.industryGeneral surgery030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasesOtorhinolaryngology030220 oncology & carcinogenesisGeneral practiceUNESCO::CIENCIAS MÉDICASGeneral Practice Dental/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSurgeryOral lichen planusbusinessLichen Planus Oral
researchProduct

Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting

2021

Background: Advanced treatment options for non-small cell lung cancer (NSCLC) consist of immunotherapy, chemotherapy, or a combination of both. Decisions surrounding NSCLC can be considered as preference-sensitive because multiple treatments exist that vary in terms of mode of administration, treatment schedules, and benefit–risk profiles. As part of the IMI PREFER project, we developed a protocol for an online preference survey for NSCLC patients exploring differences in preferences according to patient characteristics (preference heterogeneity). Moreover, this study will evaluate and compare the use of two different preference elicitation methods, the discrete choice experiment (DCE) and …

medicine.medical_specialtyMedicine (General)Health literacyTask (project management)03 medical and health scienceseducational tool0302 clinical medicineQuality of life (healthcare)R5-920SDG 3 - Good Health and Well-beingMethodsmedicineMedical physicsPreference elicitationReimbursementnon-small cell lung cancerhealth locus of controlProtocol (science)030503 health policy & servicesdiscrete choice experimentGeneral MedicinePreferenceLocus of controlquality of life030220 oncology & carcinogenesisMedicineswing weighting0305 other medical sciencePsychologyhealth literacypatient preferenceFrontiers in medicine
researchProduct